It is vital for sponsors to reduce the burden on the site if they also want to lessen the strain on patients, said Shantheri Pai, associate director clinical operations for oncology at Gilead while ...

Clinical trials have been pivotal to the improvements in public health and clinical care, leading to many millions of ...

Up to 50 transplant patients will receive a genetically modified pig kidney in a clinical trial that will launch this summer ...

Cancer researcher Karen Sfanos says she is 'terrified' of the impact of cuts to NIH funding that supports vital biomedical ...

PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP) a clinical-stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for cancer and other indications, today announced ...

Completion of SON-1010 (IL12-FHAB) monotherapy dose escalation in Phase 1 SB101 trial; Stable disease (SD) at four months post-initiation of ...

BOSTON, MA, UNITED STATES, February 13, 2025 /EINPresswire / -- When Ruihua Liu founded Hill Research, the goal was clear: to revolutionize clinical trials using Generative AI. With a background in ...

CEO Jim Frakes noted that Aethlon Medical has made significant progress in focusing on oncology and implementing cost reductions. Operating expenses were reduced by 50% compared to the same quarter ...

A researcher in the IU Luddy School of Informatics, Computing and Engineering in Indianapolis is leading efforts to develop ...

SCOPE Conference (Summit for Clinical Ops Executives), held last week in Orlando, FL, brought together more than 4,500 industry ...

TC BioPharm (TCBP) announced the first Cohort B patient in the ACHIEVE Phase 2B UK clinical trial, evaluating TCB008 in Acute Myeloid Leukemia, ...